Cell-Cell Junctions and Vascular Endothelial Growth Factor in Rat Lung as Affected by Ischemia/Reperfusion and Preconditioning With Inhaled Nitric Oxide

Journal of Surgical Research

Volumn 157, Issue 1, 2009, Pages 30-42

  Waldow, Thomas ^a   Witt, Wolfgang ^a   Janke, Andreas ^a   Ulmer, André ^a   Buzin, Anne ^a   Matschke, Klaus ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

catenin; adherens junction; lung ischemia reperfusion; nitric oxide; preconditioning; VEGF

Indexed keywords

ALPHA CATENIN; BETA CATENIN; CATENIN; CELL PROTEIN; DESMOGLEIN 1; EVANS BLUE; NITRIC OXIDE; UVOMORULIN; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL TISSUE; ARTERIAL OXYGEN TENSION; ARTICLE; CELL JUNCTION; CONTROLLED STUDY; IMMUNOPRECIPITATION; ISCHEMIA; LUNG FUNCTION; LUNG LAVAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION; THORACOTOMY;

ADHERENS JUNCTIONS; ADMINISTRATION, INHALATION; ANIMALS; BETA CATENIN; BRONCHOALVEOLAR LAVAGE FLUID; CELL MEMBRANE PERMEABILITY; DETERGENTS; DISEASE MODELS, ANIMAL; ISCHEMIC PRECONDITIONING; LUNG; LUNG DISEASES; NITRIC OXIDE; PHOSPHORYLATION; PULMONARY GAS EXCHANGE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70349846647     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.07.042     Document Type: Article

References (60)

1. dePerrot M., Liu M., Waddell T.K., et al. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 167 (2003) 490
2. Seal J.B., and Gewertz B.L. Vascular dysfunction in ischemia-reperfusion injury. Ann Vasc Surg 19 (2005) 572
3. Bazzoni G., and Dejana E. Endothelial cell-to-cell junctions: Molecular organization and role in vascular homeostasis. Physiol Rev 84 (2004) 869
4. Mehta D., and Malik A.B. Signaling mechanisms regulating endothelial permeability. Physiol Rev 86 (2006) 279
5. Yamada S., Pokutta S., Drees F., et al. Deconstructing the cadherin-catenin-actin complex. Cell 123 (2005) 889
6. Goto T., Ishizaka A., Kobayashi F., et al. Importance of tumor necrosis factor-alpha cleavage process in post-transplantation lung injury in rats. Am J Respir Crit Care Med 170 (2004) 1239
7. Godzich M., Hodnett M., Frank J.A., et al. Activation of the stress protein response prevents the development of pulmonary edema by inhibiting VEGF cell signaling in a model of lung ischemia-reperfusion injury in rats. FASEB J 20 (2006) 1519
8. Pasupathy S., and Homer-Vanniasinkam S. Ischaemic preconditioning protects against ischaemia/reperfusion injury: Emerging concepts. Eur J Vasc Endovasc Surg 29 (2005) 106
9. Downey J.M., Davis A.M., and Cohen M.V. Signaling pathways in ischemic preconditioning. Heart Fail Rev 12 (2007) 181
10. Cohen M.V., Yang X.M., and Downey J.M. Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies. Cardiovasc Res 70 (2006) 231
11. Fujino S., Nagahiro I., Triantafillou A.N., et al. Inhaled nitric oxide at the time of harvest improves early lung allograft function. Ann Thorac Surg 63 (1997) 1383
12. Guery B., Neviere R., Viget N., et al. Inhaled NO preadministration modulates local and remote ischemia-reperfusion organ injury in a rat model. J Appl Physiol 87 (1999) 47
13. Schütte H., Witzenrath M., Mayer K., et al. Short-term "preconditioning" with inhaled nitric oxide protects rabbit lungs against ischemia-reperfusion injury. Transplantation 72 (2001) 1363
14. Waldow T., Alexiou K., Witt W., et al. Protection of lung tissue against ischemia/reperfusion injury by preconditioning with inhaled nitric oxide in an in situ pig model of normothermic pulmonary ischemia. Nitric Oxide 10 (2004) 195
15. Waldow T., Alexiou K., Witt W., et al. Attenuation of reperfusion-induced systemic inflammation by preconditioning with nitric oxide in an in situ porcine model of normothermic lung ischemia. Chest 125 (2004) 2253
16. Gómez C.B., del Valle H.F., Bertolotti A., et al. Effects of short-term inhaled nitric oxide on interleukin-8 release after single-lung transplantation in pigs. J Heart Lung Transplant 24 (2005) 714
17. Vyas-Read S., Shaul P.W., Yuhanna I.S., et al. Nitric oxide attenuates epithelial - mesenchymal transition in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 293 (2007) 212
18. Moldobaeva A., Welsh-Servinsky L.E., Shimoda L.A., et al. Role of protein kinase G in barrier-protective effects of cGMP in human pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 290 (2006) 919
19. Voelkel N.F., Vandivier R.W., and Tuder R.M. Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol 290 (2006) 209
20. Waldow T., Witt W., Ulmer A., et al. Preconditioning by inhaled nitric oxide prevents hyperoxic and ischemia/reperfusion injury in rat lungs. Pulmon Pharmacol Ther 21 (2007) 418
21. Patterson C.E., Rhoades R.A., and Garcia J.G. Evans blue dye as a marker of albumin clearance in cultured endothelial monolayer and isolated lung. J Appl Physiol 72 (1992) 865
22. Waldow T., Witt W., Weber E., et al. Nitric oxide donor-induced persistent inhibition of cell adhesion protein expression and NFkappaB activation in endothelial cells. Nitric Oxide 15 (2006) 103
23. Calautti E., Cabodi S., Stein P.L., et al. Tyrosine phosphorylation and Src family kinases control keratinocyte cell-cell adhesion. J Cell Biol 141 (1998) 1449
24. Predescu D., Vogel S.M., and Malik A.B. Functional and morphological studies of protein transcytosis in continuous endothelia. Am J Physiol Lung Cell Mol Physiol 287 (2004) L895
25. Mei J.M., Borchert G.L., Donald S.P., and Phang J.M. Matrix metalloproteinase(s) mediate(s) NO-induced dissociation of β-catenin from membrane bound E-cadherin and formation of nuclear β-catenin/LEF-1 complex. Carcinogenesis 23 (2002) 2119
26. González D., Herrera B., Beltrán A., et al. Nitric oxide disrupts VE-cadherin complex in murine microvascular endothelial cells. Biochem Biophys Res Commun 304 (2003) 113
27. You D., Waeckel L., Ebrahimian T.G., et al. Increase in vascular permeability and vasodilation are critical for proangiogenic effects of stem cell therapy. Circulation 114 (2006) 328
28. Safdar Z., Wang P., Ichimura H., et al. Hyperosmolarity enhances the lung capillary barrier. J Clin Invest 112 (2003) 1541
29. Godzich M., Hodnett M., Frank J.A., et al. Activation of the stress protein response prevents the development of pulmonary edema by inhibiting VEGF cell signaling in a model of lung ischemia-reperfusion injury in rats. FASEB J 20 (2006) 757
30. Parker J.C., Stevens T., Randall J., et al. Hydraulic conductance of pulmonary microvascular and macrovascular endothelial cell monolayers. Am J Physiol Lung Cell Physiol 291 (2006) L30
31. Wang F., Daugherty B., Keise L.L., et al. Heterogeneity of claudin expression by alveolar epithelial cells. Am J Respir Cell Mol Biol 29 (2003) 62
32. González-Mariscal L., Betanzos A., Nava P., et al. Tight junction proteins. Prog Biophys Mol Biol 81 (2003) 1
33. Lum H., and Roebuck K.A. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 280 (2001) C719
34. Bush K.T., Tsukamoto T., and Nigam S.K. Selective degradation of E-cadherin and dissolution of E-cadherin-catenin complexes in epithelial ischemia. Am J Physiol Renal Physiol 278 (2000) F847
35. Lampugnani M.G., Corada M., Caveda L., et al. The molecular organization of endothelial cell to cell junctions: Differential association of plakoglobin, β-catenin, and α-catenin with vascular endothelial cadherin (VE-cadherin). J Cell Biol 129 (1995) 203
36. Scott J.A., and Yap A.S. Cinderella no longer: α-catenin steps out of cadherin's shadow. J Cell Sci 119 (2006) 4599
37. Nelson W.J., and Nusse R. Convergence of Wnt, β-catenin, and cadherin pathways. Science 303 (2004) 1483
38. Dugo L., Collin M., and Thiemermann C. Glycogen synthase kinase 3β as a target for the therapy of shock and inflammation. Shock 27 (2007) 113
39. Clevers H. Wnt/β-catenin signaling in development and disease. Cell 127 (2006) 469
40. Miyahara T., Hamanaka K., Weber D.S., et al. Phosphoinositide 3-kinase, Src, and Akt modulate acute ventilation-induced vascular permeability increases in mouse lungs. Am J Physiol Lung Cell Mol Physiol 293 (2007) L11
41. Liu F., Schaphorst K.L., Verin A.D., et al. Hepatocyte growth factor enhances endothelial cell barrier function and cortical cytoskeletal rearrangement: Potential role of glycogen synthase kinase-3β. FASEB J 16 (2002) 950
42. Failor K.L., Desyatnikov Y., Finger L.A., et al. Glucocorticoid-induced degradation of GSK3 protein is triggered by Sgk and Akt signaling and controls beta-catenin dynamics and tight junction formation in mammery epithelial tumor cells. Mol Endocrinol 21 (2007) 2403
43. Prévotat L., Filomenko R., Solary E., et al. Nitric oxide-induced down-regulation of β-catenin in colon cancer cells by a proteasome-independent specific pathway. Gastroenterology 131 (2006) 1142
44. Katsube T., Tsuji H., and Onoda M. Nitric oxide attenuates hydrogen peroxide-induced barrier disruption and protein tyrosine phosphorylation in monolayers of intestinal epithelial cell. Biochim Biophys Acta 1773 (2007) 794
45. Keck P.J., Hauser S.D., Krivi G., et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246 (1989) 1309
46. Monacci W.T., Merrill M.J., and Oldfield E.H. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol 264 (1993) C995
47. Kaner R.J., and Crystal R.G. Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung. Mol Med 7 (2001) 240
48. Thickett D.R., Armstrong L., and Millar A.B. A role for vascular endothelial growth factor in acute and resolving lung injury. Am J Respir Crit Care Med 166 (2002) 1332
49. Esser S., Lampugnani M.G., Corada M., et al. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci 111 (1998) 1853
50. Gavard J., and Gutkind J.S. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 11 (2006) 1223
51. Becker P.M., Alcasabas A., Yu A., et al. Oxygen-independent upregulation of vascular endothelial growth factor and vascular barrier dysfunction during ventilated pulmonary ischemia in isolated ferret lungs. Am J Respir Cell Mol Biol 22 (2000) 272
52. Tuder R.M., Flook B.E., and Voelkel N.F. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. J Clin Invest 95 (1995) 1798
53. Balasubramaniam V., Tang J.R., Maxey A., et al. Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse. Am J Physiol Lung Cell Mol Physiol 284 (2003) L964
54. Ekekezie I.I., Thibeault D.W., Rezaikhaligh M.H., et al. Endostatin and vascular endothelial cell growth factor (VEGF) in piglet lungs: Effect of inhaled nitric oxide and hyperoxia. Pediatr Res 53 (2003) 440
55. Lopez E., Boucherat O., Franco-Montoya M.L., et al. Nitric oxide donor restores lung growth factor and receptor expression in hyperoxia-exposed rat pups. Am J Respir Cell Mol Biol 34 (2006) 738
56. Liu Y., Christou H., Morita T., et al. Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5′ enhancer. J Biol Chem 273 (1998) 15257
57. Adhikari N.K.J., Burns K.E.A., Friedrich J.O., et al. Effect of nitric oxide on oxygenation and mortality in acute lung injury: Systematic review and meta-analysis. Br Med J 334 (2007) 779
58. Ferguson N.D. Inhaled nitric oxide for acute respiratory distress syndrome. Theoretical promise of benefit does not translate to improvements in morbidity and mortality. Br Med J 334 (2007) 757
59. Lahm T., Crisostomo P.R., Markel T.A., et al. The critical role of vascular endothelial growth factor in pulmonary vascular remodeling after lung injury. Shock 28 (2007) 4
60. Maharaj A.S., and D'Amore P.A. Roles for VEGF in the adult. Microvasc Res 74 (2007) 100